Guess which ASX 200 stock was just upgraded and tipped to rise 20%+

Bell Potter has been impressed with a recent announcement.

| More on:
A man holding a cup of coffee puts his thumb up and smiles while at laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Neuren Pharmaceuticals Ltd (ASX: NEU) share price was in fine form on Monday.

The ASX 200 stock jumped 30% to $22.20 following the release of top-line results from its Phase 2 clinical trial of NNZ-2591 in children with Phelan-McDermid syndrome (PMS).

PMS has severe quality of life impacts for those living with the syndrome, as well as parents and siblings. At present, there are no approved treatments for it despite its severely debilitating impact.

Following yesterday's gain, the pharmaceutical company's shares are now up 200% over the last 12 months.

But if you thought the gains were over, think again. That's because analysts at Bell Potter believe the company's shares can rise meaningfully from current levels.

Why this ASX 200 stock could keep rising

According to the note, the broker has upgraded Neuren's shares to a buy rating and lifted its price target on them by 54% to $27.

Based on the current Neuren share price, this implies a potential upside of approximately 22% for investors over the next 12 months.

Commenting on the ASX 200 stock's trial results, the broker said:

We have far greater confidence in NNZ-2591 following the Phase 2 results and therefore materially increase our Probability of Success in PMS and the other three indications which are similarly characterised disorders. We increase our PT to $27.00 following the increased value attributed to NNZ-2591. This represents >15% upside to the current price hence we upgrade to a BUY. Additional catalysts are expected to continue driving interest over the next 12 months, specifically (1) DAYBUE quarterly updates in the US, (2) DAYBUE submissions in Canada & Europe, (3) additional NNZ2591 Phase 2 results, and (4) NNZ-2591 Phase 3 preparations.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A cute young girl with curly hair sips a glass of milk through a straw with a smile on her face.
Broker Notes

Up 37% this year, why Macquarie expects A2 Milk shares to keep outperforming

Macquarie remains bullish on A2 Milk shares heading into 2026. Let’s see why.

Read more »

ASX shares Business man marking buy on board and underlining it
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

An older female ASX investor holds a gangster-style fist pump pose showing off gold rings with dollar signs on them.
Broker Notes

Why Macquarie forecasts Northern Star shares are set to surge 55%

Macquarie believes Northern Star shares are well-placed to rocket higher.

Read more »

Two miners examine things they have taken out the ground.
Broker Notes

Up 64% this year! What's Macquarie's price target for Lynas Rare Earths shares?

Clouds on the horizon?

Read more »

a group of people in business attire gather around a computer in an office environment with expressions of concern as they try to nut out the answer to a challenge they are facing.
Broker Notes

Leading broker just downgraded the Fortescue share price. Is it time to sell?

Downside ahead for the iron ore titan?

Read more »

a man sits back from his laptop computer with both hands behind his head feeling happy to see the Brambles share price moving significantly higher today
Broker Notes

Broker tips Domino's Pizza share price to rise 54% in FY26

Ord Minnett says the current Domino's Pizza share price offers "very attractive value".

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Broker Notes

These ASX 200 shares could rise 50% to 60%

Brokers believe these shares could deliver big returns for investors.

Read more »